SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-028601
Filing Date
2023-06-16
Accepted
2023-06-16 16:08:48
Documents
13
Period of Report
2023-06-15
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K nuvl-20230615.htm   iXBRL 8-K 103732
2 EX-3.1 nuvl-ex3_1.htm EX-3.1 173296
  Complete submission text file 0000950170-23-028601.txt   434196

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT nuvl-20230615.xsd EX-101.SCH 2474
4 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT nuvl-20230615_pre.xml EX-101.PRE 11997
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT nuvl-20230615_lab.xml EX-101.LAB 19063
7 EXTRACTED XBRL INSTANCE DOCUMENT nuvl-20230615_htm.xml XML 5064
Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142 508-446-2272
Nuvalent, Inc. (Filer) CIK: 0001861560 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40671 | Film No.: 231021127
SIC: 2834 Pharmaceutical Preparations